Dr. Julia Warren Valdez, MD

Dr. Valdez practices at Valdez Eye Center in Apple Valley, California.

Dr. Valdez's NPI, 1205855285, was assigned on July 19, 2006. Dr. Valdez graduated from University of the Philippines College of Medicine in 1984. Dr. Valdez holds California license A53489.

Dr. Valdez's primary practice is Valdez Eye Center, at 16031 Tuscola Rd, Apple Valley, CA 92307. The practice phone is (760) 946-2020.

Dr. Valdez's primary practice is Valdez Eye Center in Apple Valley, California. Dr. Valdez is also affiliated with Providence St. Mary Medical Center. Dmand AI also links Dr. Valdez to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Valdez practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Valdez's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Valdez is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Valdez's licenses on file in 2 states: California and Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Dr. Valdez treats.

CMS data shows 1,870 Medicare services from Dr. Valdez across 14 procedure codes in 2024, for 702 Medicare patients. Medicare paid $145,438 for them.

CMS counts 702 Medicare patients who saw Dr. Valdez in 2024. The largest group is 65 to 74, with 277 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Valdez's median patient age at 65, with 61% women.

In 2024, Dr. Valdez wrote 1,627 Medicare Part D claims for 472 patients. 50% of them were for generic drugs. CMS names the drug for 1,557 of them, across 18 drugs with 11 or more claims each, at $288,525 in total drug cost. In 2023, CMS named 1,825 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Valdez for performance year 2024, reported individually. Dr. Valdez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 116 procedures of cataract surgery by Dr. Valdez, more than 76% of the clinicians it reports for that procedure.

CMS Open Payments shows 87 general payments to Dr. Valdez from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Shire North American Group Inc paid the most, $348.

Dmand AI lists 2 awards for Dr. Valdez, most recently AAO Fellow in 2013.

Dr. Valdez graduated from University of the Philippines College of Medicine in 1984. Dr. Valdez is a member of AAO.

Dr. Valdez is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.